D-1553: A novel KRAS G12C inhibitor with potent and selective cellular and in vivo antitumor activity.

MLA

Shi, Zhe, et al. “D-1553: A Novel KRAS G12C Inhibitor with Potent and Selective Cellular and in Vivo Antitumor Activity.” Cancer Science, vol. 114, no. 7, July 2023, pp. 2951–60. EBSCOhost, https://doi.org/10.1111/cas.15829.

APA

Shi, Z., Weng, J., Niu, H., Yang, H., Liu, R., Weng, Y., Zhu, Q., Zhang, Y., Tao, L., Wang, Z., Huh, S. J., Jiang, Y., Mei, H., Dai, X., Zhang, L., & Wang, Y. (2023). D-1553: A novel KRAS G12C inhibitor with potent and selective cellular and in vivo antitumor activity. Cancer Science, 114(7), 2951–2960. https://doi.org/10.1111/cas.15829

Chicago

Shi, Zhe, Jifang Weng, Haotao Niu, Hong Yang, Rongfeng Liu, Yan Weng, Qingqing Zhu, et al. 2023. “D-1553: A Novel KRAS G12C Inhibitor with Potent and Selective Cellular and in Vivo Antitumor Activity.” Cancer Science 114 (7): 2951–60. doi:10.1111/cas.15829.